⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18721401 | 1.00 | — | — | |
| SCHEMBL1651050 | 0.64 | — | — | |
| SCHEMBL19346764 | 0.64 | — | — | |
| SCHEMBL11282501 | 0.63 | — | — | |
| SCHEMBL16869294 | 0.61 | — | — | |
| SCHEMBL23262204 | 0.58 | LMNA (0.57) | — | |
| SCHEMBL16264920 | 0.56 | GAA (0.35) | — | |
| SCHEMBL8611 | 0.55 | — | — | |
| SCHEMBL21379879 | 0.54 | — | — | |
| SCHEMBL20613480 | 0.54 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023143263-A1 | ANTIBODY AGAINST HER3, CONJUGATE AND USE THEREOF | 苏州宜联生物医药有限公司 | 2023-08-03 | — | — | WO | disclosed |
| EP-3053600-B1 | CYTOTOXIC BENZODIAZEPINE DERIVATIVES | IMMUNOGEN INC (US) | 2020-01-29 | — | — | EP | disclosed |
| EP-2277510-B1 | Controlled release preparation | TAKEDA PHARMACEUTICALS CO (JP) | 2018-12-26 | — | — | EP | disclosed |
| EP-2275088-B2 | Method for producing granules | TAKEDA PHARMACEUTICALS CO (JP) | 2018-09-26 | — | — | EP | disclosed |
| US-9688627-B2 | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | CAYMAN CHEMICAL COMPANY, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| EP-1602362-B1 | DRUG COMPOSITION HAVING ACTIVE INGREDIENT ADHERED AT HIGH CONCENTRATION TO SPHERICAL CORE | TAKEDA PHARMACEUTICAL (JP) | 2016-09-28 | — | — | EP | disclosed |
| US-20160128945-A1 | CONTROLLED RELEASE PREPARATION | TAKEDA PHARMACEUTICAL (JP) | 2016-05-12 | — | — | US | disclosed |
| EP-2275088-B1 | Method for producing granules | TAKEDA PHARMACEUTICAL (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-8980322-B2 | Controlled release composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-03-17 | — | — | US | disclosed |
| US-20150072015-A1 | METHOD FOR PRODUCING GRANULES | TAKEDA PHARMACEUTICAL (JP) | 2015-03-12 | — | — | US | disclosed |
| US-20070141137-A1 | Stable capsule preparation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20060293371-A1 | Prodrug and process for producing the same | TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. (US) | 2006-12-28 | — | — | US | disclosed |
| EP-1721604-A1 | STABLE CAPSULE PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2006-11-15 | — | — | EP | disclosed |
| US-20060177509-A1 | Controlled release composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-08-10 | — | — | US | disclosed |
| US-20060159760-A1 | Drug composition having active ingredient adhered at high concentration to spherical core | AOYAMA & PARTNERS | 2006-07-20 | — | — | US | disclosed |
| US-20060013868-A1 | Controlled release preparation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-01-19 | — | — | US | disclosed |
| EP-1607088-A1 | CONTROLLED RELEASE COMPOSITION | Takeda Pharmaceutical Company Limited (JP) | 2005-12-21 | — | — | EP | disclosed |
| EP-1602362-A1 | DRUG COMPOSITION HAVING ACTIVE INGREDIENT ADHERED AT HIGH CONCENTRATION TO SPHERICAL CORE | Takeda Pharmaceutical Company Limited (JP) | 2005-12-07 | — | — | EP | disclosed |
| US-20050222210-A1 | Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-10-06 | — | — | US | disclosed |
| EP-1514870-A1 | PRODRUG AND PROCESS FOR PRODUCING THE SAME | Takeda Pharmaceutical Company Limited (JP) | 2005-03-16 | — | — | EP | disclosed |